Hiroshi Sakonjo

928 total citations
27 papers, 787 citations indexed

About

Hiroshi Sakonjo is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Hiroshi Sakonjo has authored 27 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Hiroshi Sakonjo's work include Renin-Angiotensin System Studies (10 papers), Hormonal Regulation and Hypertension (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Hiroshi Sakonjo is often cited by papers focused on Renin-Angiotensin System Studies (10 papers), Hormonal Regulation and Hypertension (6 papers) and Blood Pressure and Hypertension Studies (5 papers). Hiroshi Sakonjo collaborates with scholars based in Japan and United States. Hiroshi Sakonjo's co-authors include Shinji Takai, Mizuo Miyazaki, Denan Jin, Mizuo Miyazaki, Ryuichi Morishita, Toshio Ogihara, Jitsuo Higaki, Kunio Matsumoto, Toshikazu Nakamura and Hideki Okunishi and has published in prestigious journals such as Circulation, FEBS Letters and Hypertension.

In The Last Decade

Hiroshi Sakonjo

26 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Sakonjo Japan 15 331 238 209 205 198 27 787
Jan Willem N. Akkerman Netherlands 18 280 0.8× 254 1.1× 227 1.1× 135 0.7× 95 0.5× 29 1.2k
Roger van Kruchten Netherlands 14 325 1.0× 387 1.6× 233 1.1× 158 0.8× 296 1.5× 18 1.6k
Yutaka Hisada Japan 9 344 1.0× 307 1.3× 83 0.4× 198 1.0× 128 0.6× 10 763
Yumiko Matsubara Japan 16 183 0.6× 138 0.6× 118 0.6× 85 0.4× 196 1.0× 32 975
Hongmei Peng China 12 337 1.0× 216 0.9× 99 0.5× 117 0.6× 72 0.4× 34 719
Yuichiro Adachi Japan 15 342 1.0× 286 1.2× 87 0.4× 128 0.6× 149 0.8× 39 879
Naifeng Liu China 18 172 0.5× 377 1.6× 135 0.6× 102 0.5× 85 0.4× 51 878
Yoshikage Yo Japan 11 210 0.6× 245 1.0× 296 1.4× 66 0.3× 72 0.4× 15 838
Takehiko Yamada Japan 14 708 2.1× 490 2.1× 109 0.5× 222 1.1× 152 0.8× 30 1.1k
Hirosuke Kouchi Japan 5 221 0.7× 370 1.6× 167 0.8× 41 0.2× 79 0.4× 9 749

Countries citing papers authored by Hiroshi Sakonjo

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Sakonjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Sakonjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Sakonjo more than expected).

Fields of papers citing papers by Hiroshi Sakonjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Sakonjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Sakonjo. The network helps show where Hiroshi Sakonjo may publish in the future.

Co-authorship network of co-authors of Hiroshi Sakonjo

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Sakonjo. A scholar is included among the top collaborators of Hiroshi Sakonjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Sakonjo. Hiroshi Sakonjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tawa, Masashi, Hiroshi Sakonjo, Takayoshi Masuoka, et al.. (2019). Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery. Journal of Vascular Research. 56(3). 109–116. 3 indexed citations
2.
Takai, Shinji, Denan Jin, Hiroshi Sakonjo, Takayuki Takubo, & Toyofumi Nakanishi. (2013). Significance of the Vascular Concentration of Angiotensin II–Receptor Blockers on the Mechanism of Lowering Blood Pressure in Spontaneously Hypertensive Rats. Journal of Pharmacological Sciences. 123(4). 371–379. 7 indexed citations
3.
Jin, Denan, Shinji Takai, Hiroshi Sakonjo, et al.. (2012). Outside Fibroblasts Play a Key Role in the Development of Inner Neointima After the Implantation of Polytetrafluoroethylene Grafts. Journal of Pharmacological Sciences. 119(2). 139–149. 8 indexed citations
4.
Takai, Shinji, et al.. (2010). Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats. Hypertension Research. 34(2). 245–252. 9 indexed citations
5.
Takai, Shinji, Denan Jin, Hiroshi Sakonjo, & Mizuo Miyazaki. (2010). Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats. Hypertension Research. 33(9). 953–959. 8 indexed citations
6.
Takai, Shinji, Denan Jin, Hironobu Ikeda, Hiroshi Sakonjo, & Mizuo Miyazaki. (2009). Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats. Hypertension Research. 32(10). 853–860. 13 indexed citations
7.
Ogawa, Masami, Hiroshi Sakonjo, & C Kamei. (2009). Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice. Immunopharmacology and Immunotoxicology. 31(4). 601–606. 3 indexed citations
9.
Takai, Shinji, Denan Jin, Masato Sakaguchi, et al.. (2004). Comparative Effects of Candesartan and Amlodipine in a Monkey Atherosclerotic Model. Hypertension Research. 27(7). 517–522. 14 indexed citations
10.
Takai, Shinji, Hiroshi Sakonjo, Denan Jin, et al.. (2003). A Novel Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppressed Intimal Hyperplasia after Balloon Injury. Journal of Pharmacology and Experimental Therapeutics. 304(2). 841–844. 34 indexed citations
11.
Takai, Shinji, Shokei Kim, Hiroshi Sakonjo, & Mizuo Miyazaki. (2003). Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet. Journal of Hypertension. 21(2). 361–369. 25 indexed citations
12.
Yamasaki, Kazuhiko, Tatsuya Asai, Masahiro Shimizu, et al.. (2003). Inhibition of NFκB activation using cis-element ‘decoy’ of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Therapy. 10(4). 356–364. 57 indexed citations
13.
Nakamura, Takashi, Ryuichi Morishita, Tatsuya Asai, et al.. (2002). Molecular strategy using cis-element ‘decoy’ of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model. Gene Therapy. 9(8). 488–494. 16 indexed citations
14.
Takai, Shinji, Hiroshi Sakonjo, & Mizuo Miyazaki. (2001). Beneficial Effect of Trandolapril on the Lifespan of a Severe Hypertensive Model.. Hypertension Research. 24(5). 559–564. 13 indexed citations
15.
Miyazaki, Mizuo, Hiroshi Sakonjo, & Shinji Takai. (1999). Anti‐atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high‐cholesterol diet. British Journal of Pharmacology. 128(3). 523–529. 70 indexed citations
16.
Suzuki, Jun, et al.. (1993). Antihypertensive Effects of Bopindolol in Renal Hypertensive Dogs and Effects of Its Active Metabolite (18-502) on Blood Flow of Femoral Arteries in Dogs.. 46(2). 81–88. 1 indexed citations
17.
Shiota, Naotaka, Hideki Okunishi, Akiyoshi Fukamizu, et al.. (1993). Activation of two angiotensin‐generating systems in the balloon‐injured artery. FEBS Letters. 323(3). 239–242. 79 indexed citations
18.
Sakonjo, Hiroshi. (1993). Pharmacological Action of a Novel Angiotensin Converting Enzyme (ACE) Inhibitor, RU44570, namely (-)-(2S, 3aR, 7aS)-1-[(S)-N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid: In vivo ACE Inhibiting Effect and Antihypertensive Effect in Various Hypertensive Models of Rats.. Medical Entomology and Zoology. 45. 15–25. 3 indexed citations
19.
Kawamoto, Tatsuhiko, et al.. (1992). Mechanism underlying the prolonged effect of a new angiotensin-converting enzyme (ACE) inhibitor, trandolapril. The Japanese Journal of Pharmacology. 58. 68–68.
20.
Sakonjo, Hiroshi, et al.. (1986). Effects of somatostatin and its analogue, des (Ala1, Gly2) (D-Trp8, D-Asu3,14)-somatostatin (SS-1), on gastric mucosal blood flow and gastric secretion.. Folia Pharmacologica Japonica. 87(5). 551–556. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026